Psyence Biomedical Ltd. PBM
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -1.46M | -- |
| Total Depreciation and Amortization | -- | -- | -- | 4.60K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -2.16M | -- |
| Change in Net Operating Assets | -- | -- | -- | -375.60K | -- |
| Cash from Operations | -- | -- | -- | -3.99M | -- |
| Capital Expenditure | -- | -- | -- | -6.70K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -2.01M | -- |
| Cash from Investing | -- | -- | -- | -2.02M | -- |
| Total Debt Issued | -- | -- | -- | 500.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 1.74M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 9.08M | -- |
| Cash from Financing | -- | -- | -- | 11.32M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 5.31M | -- |